IMIC(SZ:000516) Sou Hu Cai Jing·2025-08-11 10:49Group 1 - The core viewpoint of the article highlights the financial performance and stock activity of International Medicine (000516) as of August 11, 2025, with a closing price of 5.41 yuan, reflecting a 0.74% increase [1] - The company reported a total operating revenue of 999.7 million yuan for Q1 2025, representing a year-on-year decrease of 14.99%, and a net profit attributable to shareholders of 106.35 million yuan, down 1.37% year-on-year [1] - The company's liquidity ratios are low, with a current ratio of 0.333 and a quick ratio of 0.318, alongside a high debt-to-asset ratio of 67.64% [1] Group 2 - The stock experienced a net outflow of 13.25 million yuan in principal funds, accounting for 7.93% of the total transaction amount, with significant outflows from large orders [1] - International Medicine has invested in 43 external enterprises and holds 2 trademark registrations, along with 26 administrative licenses [2]